Physiologically, the inhibitors of mTORCs are Tuberous Sclerosis Complex 1 (TSC1) and TSC2 proteins, which are important tumor suppressors that inhibit cell growth (Figure 1). This evidence concerns the gene TSC1 and neoplasm.